ORAGENICS, INC. Deferred Revenue
ORAGENICS, INC. (OGEN) had Deferred Revenue of $0 as of 2016-12-31, per its 10-K filed 2017-02-27.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2017-02-27
- 2016-12-31: Deferred Revenue, Current $0.00.
- 2016-09-30: Deferred Revenue, Current $0.00.
- 2016-06-30: Deferred Revenue, Current $0.00.
- 2016-03-31: Deferred Revenue, Current $17.69K.
| Period end | Deferred Revenue, Current |
|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-02-27 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-14 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-15 |
| 2016-03-31 | $17.69K 10-Q · filed 2016-05-16 |
| 2015-12-31 | $14.21K 10-Q · filed 2016-05-16 |
| 2015-09-30 | $15.34K 10-Q · filed 2015-11-06 |
| 2015-06-30 | $17.86K 10-Q · filed 2015-08-07 |
| 2015-03-31 | $17.28K 10-Q · filed 2015-05-08 |
| 2014-12-31 | $21.22K 10-K · filed 2016-03-30 |
| 2014-09-30 | $25.59K 10-Q · filed 2014-11-03 |
| 2014-06-30 | $38.88K 10-Q · filed 2014-08-07 |
| 2014-03-31 | $50.40K 10-Q · filed 2014-05-09 |
| 2013-12-31 | $18.84K 10-K · filed 2015-02-27 |
| 2013-09-30 | $23.71K 10-Q · filed 2013-10-25 |
| 2013-06-30 | $23.15K 10-Q · filed 2013-08-12 |
| 2013-03-31 | $24.11K 10-Q · filed 2013-05-15 |
| 2012-12-31 | $50.99K 10-K · filed 2014-02-28 |
| 2012-09-30 | $265.84K 10-Q · filed 2012-11-14 |
| 2012-06-30 | $85.32K 10-Q · filed 2012-08-10 |
| 2012-03-31 | $145.20K 10-Q · filed 2012-05-15 |
| 2011-12-31 | $152.96K 10-K · filed 2013-03-26 |
| 2011-09-30 | $161.38K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $115.59K 10-Q · filed 2011-08-05 |
| 2010-12-31 | $13.19K 10-K · filed 2012-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |